Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.72
3.42103.63%
Last update: Dec 15, 3:15 PM
Comments
Loading...
Artiva Biotherapeutics (ARTV) Stock Price, Quote, News & History
ARTVNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Artiva Biotherapeutics (ARTV) stock?
You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.
Who are Artiva Biotherapeutics (ARTV) competitors?
Other companies in Artiva Biotherapeutics’s space includes: Macrogenics Inc (NASDAQ:MGNX), Outlook Therapeutics Inc (NASDAQ:OTLK), Fortress Biotech Inc (NASDAQ:FBIO), Tharimmune Inc (NASDAQ:THAR) and Korro Bio Inc (NASDAQ:KRRO).
What is the forecast, or price target, for Artiva Biotherapeutics (ARTV) stock?
Artiva Biotherapeutics has a consensus price target of $19.29.
What is the current price for Artiva Biotherapeutics (ARTV)?
The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $6.7199 last updated December 15, 2025 at 3:15 PM EST.
Does Artiva Biotherapeutics (ARTV) pay a dividend?
There are no upcoming dividends for Artiva Biotherapeutics.
When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?
Artiva Biotherapeutics does not have any upcoming earnings scheduled.
Is Artiva Biotherapeutics (ARTV) going to split?
There is no upcoming split for Artiva Biotherapeutics.
What sector and industry does Artiva Biotherapeutics (ARTV) operate in?
Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
